Acute Myeloid Leukemia (AML)

Dr. Stein is a hematology-oncology physician who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. He is dedicated to providing my patients with the best care tailored to their unique situation. To do this, he works together with patients to develop a personalized treatment plan that takes into account their needs as well as their family’s. Dr. Stein is also an active clinical researcher who develops new and innovative approaches to treating acute myeloid leukemia (AML).

Maxim Norkin, MD, PhD, is board certified in hematology and oncology with clinical expertise in hematological malignancies and bone marrow transplantation. An advisory group member of the National Marrow Donor Program, Dr. Norkin has served as a principal investigator on multiple clinical trials and is dedicated to providing the best evidenced-based care to his patients.

Dr. Nimer has been conducting extensive clinical and basic science research into the treatment, and genetic basis of adult leukemia and bone marrow failure states, defining the regulatory mechanisms that control the production of blood cells and exploring ways to improve the treatment of blood-based cancers.

Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania. She joined Dana-Farber as a member of the Adult Leukemia program in 2016.

Melhem Solh, M.D., is board certified in the subspecialties of medical oncology and hematology. Dr. Solh is a Northside Hospital Blood and Marrow Transplant and Leukemia Program physician.In 2019, Dr. Solh was recognized as among Atlanta’s Top Doctors in his specialty by Castle Connolly.

Saurabh Chhabra, MD, received his Medical Degree from the University of Delhi in 2002. He completed his Internal Medicine Residency at Rutgers-Robert Wood Johnson Medical School in New Brunswick, NJ in 2008. He then went on to complete his Fellowship in Hematology/Oncology at Cancer Institute of New Jersey in 2011. Dr. Chhabra then moved to Stanford University, Stanford, CA and completed his Fellowship in Blood and Marrow Transplantation in 2012. He was recruited to Medical University of South Carolina, Charleston, SC in 2012, where he was a member of the Hematologic Malignancies and BMT

Dr. Timothy Pardee specializes in hematology and oncology with Wake Forest Baptist Health in Winston-Salem, North Carolina. He is also the director of Leukemia Translational Research.

Dr. Michael Burke is an Associate Professor at the Children’s Hospital of Wisconsin (CHW) in the Division of Hematology/Oncology/Blood & Marrow Transplantation. He is Director of the Pediatric Leukemia & Lymphoma Program at CHW and Co-Director of the Developmental Therapeutics Program where he oversees all early phase clinical trials (Phase I and II studies) at CHW. He has developed both early phase and upfront clinical trials in acute leukemia that have opened locally here at CHW as well as nationally and internationally through consortiums such as the Children’s Oncology Group (COG) and the